The AI marketing gap looks different in every industry.

Your product sounds like every other AI-written SaaS in your category.

Every SaaS company is now pumping out AI-generated content at scale. The result is a sea of identical copy, identical positioning, and identical ad creative. Your brand voice is drowning in the average. Meanwhile, when a prospect asks ChatGPT to recommend a tool, your name isn't coming up — a better-positioned competitor is.

A VP of Operations asks ChatGPT: “What's the best project management tool for a remote engineering team?” Your product doesn't appear. A funded competitor does — three times.

position in AI answers for your core category query is worth more than a full page of Google ads. We make you that answer.

SaaS buyers are asking AI for recommendations before they ever hit your site. This package audits your current share of model and builds the strategy to grow it — fast.

One AI hallucination about a drug claim could cost you more than your entire marketing budget.

Pharmaceutical marketing sits at the intersection of AI's biggest weakness — accuracy — and your industry's biggest risk — regulatory compliance. AI tools can generate medical copy at volume, but they cannot guarantee factual accuracy, FDA-compliant language, or the absence of dangerous misinformation.

Your marketing team uses AI to generate physician outreach emails. One email contains a subtle misstatement about an indication. It goes out to 4,000 HCPs before anyone notices. Legal is now involved.

is the acceptable cost of a regulatory violation. Our Human-in-the-Loop QA layer is the difference between scale and exposure.

For pharma, this is non-negotiable. We build the compliance framework, train your AI tools within it, and provide the human editorial layer that keeps every output legally defensible.

Hospital procurement teams are using AI to shortlist surgical vendors before your sales rep gets a call.

Medical device sales cycles are long, technical, and relationship-driven. But the first filter is increasingly digital — procurement committees and clinical champions are querying AI tools for vendor comparisons before they initiate contact. If you're not in those AI answers, you're not in the consideration set.

A hospital procurement lead asks Perplexity: “Compare the top three vendors for minimally invasive laparoscopic devices.” Your company doesn't appear — two smaller competitors with better-structured clinical content do.

of B2B buyers now use AI tools to research vendors before initiating contact. Medical device procurement is no different.

Source: ¹ Loganix, "B2B AI Buying Behavior Report" (2026).

Start by fixing the data foundation. Your clinical and sales CRM data is the fuel for every AI tool in your stack. We clean it, structure it, and make it LLM-ready in 30 days.

Industrial buyers are finding vendors through AI — and your digital presence wasn't built for that.

Manufacturing marketing has historically relied on trade shows, distributor relationships, and inbound from outdated websites. That model is being disrupted fast. Procurement teams are now using AI tools to identify, compare, and shortlist suppliers. If your product specs, case studies, and certifications aren't structured for AI ingestion, you're invisible in the new buying process.

A plant manager asks ChatGPT: “Which precision CNC machining companies in the Midwest have ISO 9001 certification and can handle tolerances under 0.001 inches?” Your company ticks every box — but doesn't appear.

of industrial procurement decisions involve AI-assisted vendor research at some stage. Most manufacturers have zero visibility in those searches.

Industrial buyers are already asking AI for vendor recommendations. This package ensures your capabilities, certifications, and differentiators are what AI surfaces when they do.

You're paying for AI tools that aren't working — because your data is a mess.

Small and medium businesses are adopting AI marketing tools faster than any other segment. But most SMBs are feeding smart tools dirty data — fragmented CRMs, inconsistent customer records, no conversion tracking. The result: AI automation that makes poor decisions at scale, and brand voice getting diluted by generic content that sounds like every other small business.

You spend $400/month on an AI email marketing tool. It's generating campaigns based on a CRM with 40% duplicate contacts, outdated segments, and no purchase history. Open rates are 8%. You blame the tool. The real problem is the data.

average improvement in AI marketing tool performance after a data hygiene audit. Clean data is the unlock — not a bigger budget.

Source: ¹ Macaw Digital analysis, directional estimate based on client benchmarking.

This is the right starting point for SMBs. In 30 days, we clean your data, fix your tracking, and give you a roadmap — so every AI tool you're already paying for actually works.

Forty-seven people are using AI with forty-seven different prompts. Your brand is being written by a statistical average.

Enterprise organisations face a different AI problem: not adoption, but governance. Dozens of marketing team members are independently using AI tools with no shared brand framework, no compliance layer, and no unified strategy. The result is brand fragmentation at scale, legal exposure from ungoverned outputs, and a patchwork of disconnected tools.

Your global marketing team of 60 uses ChatGPT, Jasper, Midjourney, and six other AI tools. There is no shared prompt library, no brand voice document, and no review process. Legal has flagged three AI-generated assets this quarter. Brand consistency scores are at a three-year low.

of enterprise CMOs say AI governance is their top marketing risk for 2025. We build the framework that turns risk into competitive advantage.

Enterprise needs typically span all three packages. We scope a custom engagement that covers governance, data architecture, and AEO — with dedicated support and quarterly strategy reviews.